Exercise cardiopulmonary magnetic resonance imaging unmasks worsening cardiovascular haemodynamics in the spectrum of heart failure with preserved ejection fraction (HFpEF)
Empagliflozin reduces extracellular volume and myocardial sodium content in patients with heart failure and preserved ejection fraction and correlates with reverse cardiac remodeling (EMPAG CMR-HF)
Left atrial-to-left ventricular indexed volume ratio: a potential prognostic marker for adverse outcomes in patients with heart failure and reduced left ventricular ejection fraction
Cardiac magnetic resonance-derived left atrioventricular coupling index for prognostic stratification in patients with reduced ejection fraction: insights from the DERIVATE Registry